Skip to Content

GP 122 (Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg)

Pill imprint GP 122 has been identified as Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg.

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; migraine prevention; alport syndrome; heart attack (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 12.5 mg / 20 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg GP 122
Hydrochlorothiazide and lisinopril
GP 122
12.5 mg / 20 mg
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.